Investigators
Study information
- Research Area: This is a nationwide population-based study that will concern the population screened for HBV and HCV in all Rwandan district
- Research type: We will include data for more than 1 million individuals tested for HCV and HBV in Rwanda. This dataset has information on socio-demographic, HBV and HCV testing and treatment outcome, HIV coinfection, clinical characteristics, prescription drugs, chronic disease, complications, and death and this information will be considered.
- Start date: Jul 27, 2021
- End date: Jul 31, 2023
Study aim of the objectives
This project aims to describe the uptake of hepatitis c treatment among people with HCV mono-infection and those with hepatitis b virus (HBV) co-infection and assess the factors for the low treatment uptake in Rwanda. Another objective will be to characterize the treatment outcomes among people with HBV and HCV coinfection in Rwanda and factors associated with the cure rate.
Study setting/Area (Location)
Countrywide
Implementing institution
Rwanda Biomedical Center
Department/Division
IHDPC/HIV, STIs and Viral Hepatitis Division
Impact on Policy
To inform treatment guidelines